Horton Capital Management is an investment fund managing more than $73.4 million ran by David Achey. There are currently 5 companies in Mr. Achey’s portfolio. The largest investments include Repro Med Sys Inc and UroGen Pharma Ltd, together worth $59.3 million.
As of 5th November 2021, Horton Capital Management’s top holding is 10,745,632 shares of Repro Med Sys Inc currently worth over $49.8 million and making up 67.8% of the portfolio value.
In addition, the fund holds 628,075 shares of UroGen Pharma Ltd worth $9.59 million, whose value grew 3.6% in the past six months.
The third-largest holding is Wireless Telecom worth $8.9 million and the next is Safeguard Scientifics worth $3.74 million, with 482,108 shares owned.
Currently, Horton Capital Management's portfolio is worth at least $73.4 million. The total portfolio value may be much higher due to cash
assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.
The Horton Capital Management office and employees reside in Philadelphia, Pennsylvania. According to the last 13-F report filed with the SEC, David Achey serves as the Chief Compliance Officer at Horton Capital Management.
In the most recent 13F filing, Horton Capital Management revealed that it had increased its stake in Repro Med Sys Inc and bought 4,038 additional shares worth around .
The two most similar investment funds to Horton Capital Management are Key Colony Management and Brookfield Bhs Advisors. They manage $49.2 million and $49.7 million respectively.
Horton Capital Management’s portfolio is diversified across 5 sectors.
Currently, their heaviest sector is Health Care — making up 13.1% of
the total portfolio value.
The fund focuses on investments in the United States as
80.0% of the portfolio companies
are based in the United States.
The majority of the companies in the fund’s portfolio are small-cap stocks.
Stocks with a size of more than $100 million in market cap make up
40% of the total holdings value.
On the other hand, large-cap stocks make up only approximately 0.1% of the portfolio.
The average market cap of the portfolio companies is close to $164 million.
These positions were updated on November 12th based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.
| Security | Shares Owned | Value | Allocation |
|---|---|---|---|
| Repro Med Sys Inc |
0.04%
10,745,632
|
$49,752,000 | 67.76% |
| UroGen Pharma Ltd |
1.42%
628,075
|
$9,591,000 | 13.06% |
| Wireless Telecom Group, Inc. |
No change
2,185,804
|
$8,896,000 | 12.12% |
| Safeguard Scientifics, Inc. |
No change
482,108
|
$3,741,000 | 5.10% |
| CynergisTek Inc |
No change
710,004
|
$1,441,000 | 1.96% |
| No transactions found | |||
| Showing first 500 out of 5 holdings | |||